Urokinase plasminogen activator (uPA) and urokinase plasminogen activator receptor (uPAR) are up-regulated in tumors of various origins, where they play critical roles in the development of invasive and chemo-resistant cancer phenotypes. The gene discussed is PLAUR; the disease is cancer.